Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genentech Thinks Pertuzumab Will Escape Avastin Problem, Despite Similarities

Dec 12 2011

• By Emily Hayes

Related Content

Roche's T-DM1 Early Filing Strategy Backfires As FDA Refuses To File BLA

Aug 30 2010

Avastin Loses Its Breast Cancer Claim; FDA’s Hamburg Opts For Withdrawal Over Restrictions

Nov 18 2011

<em>Avastin</em> Decision Leaves Lingering Uncertainty As To Threshold Level Of Progression-Free Survival Benefit

Nov 28 2011

Avastin Loses Its Breast Cancer Claim; FDA’s Hamburg Opts For Withdrawal Over Restrictions

Nov 21 2011

Related Companies

Genentech, Inc.

Pfizer Inc.

Roche Holding AG

ImmunoGen, Inc.

GSK plc

Puma Biotechnology, Inc.

Boehringer Ingelheim GmbH

Additional Topics

Clinical Trials Research & Development Drug Approval Standards BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window